Spectral Medical (TSE:EDT) Releases Quarterly Earnings Results

Spectral Medical (TSE:EDT) posted its quarterly earnings data on Friday. The company reported C($0.01) earnings per share for the quarter, FiscalAI reports. The firm had revenue of C$0.89 million during the quarter.

Spectral Medical Stock Up 5.1%

EDT stock opened at C$1.43 on Friday. The company has a debt-to-equity ratio of 26.03, a current ratio of 0.61 and a quick ratio of 0.45. The stock has a market capitalization of C$419.59 million, a P/E ratio of -8.94 and a beta of 0.65. The business has a 50-day moving average of C$1.36 and a 200-day moving average of C$1.36. Spectral Medical has a fifty-two week low of C$0.77 and a fifty-two week high of C$1.84.

About Spectral Medical

Spectral Medical Inc is focused on the development and commercialization of a treatment for septic shock utilizing its endotoxin activity assay (EAA) diagnostic and the toraymyxin therapeutic. The company also manufactures and sells proprietary reagents. The product line of the company consists of proprietary biochemical, EAA, and instrumentation. The segments of the group are Spectral Medical Inc, which is the key revenue-generating segment that manufactures and sells its EAA diagnostic and certain proprietary reagents; Dialco Medical Inc segment; and Corporate.